ClinicalTrials.Veeva

Menu

International Multicenter Study One Day Prevalence Observational Study for Delirium on ICU (IMPROVE-ICU)

C

Claudia Spies

Status

Completed

Conditions

Delirium

Study type

Observational

Funder types

Other

Identifiers

NCT01278524
IMPROVE-ICU

Details and patient eligibility

About

An anonymous international multicenter - clinical survey, one-day observational study.

Full description

Delirium is a serious complication in postoperative and critically ill patients and is independently associated with cognitive impairment at hospital discharge and with significantly higher 6-month mortality. Furthermore, ICU delirium is associated with more days requiring mechanically ventilation, longer ICU length of stay, and longer hospital length of stay. More recently a study by Pisani and co-workers' could show an association between days of delirium and mortality; - each additional day spent in delirium is associated with a 20% increased risk of prolonged hospitalization - translating to over 10 additional days - and a 10% increased risk of death.The reported prevalence of delirium in critically ill patients ranges widely from 11% to 87%. The aim of our study is to investigate the implementation rate of routine delirium assessment in European ICUs.

Enrollment

1,002 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients staying in the ICU on the 25th of January (one-day prevalence study)

No exclusion Criteria:

Trial design

1,002 participants in 1 patient group

Critically ill patients
Description:
Patients staying in the ICU on the 25th of January

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems